fbpx

Celgene’s Q2 Profit Surges on Drug Sales

Jessica Perry//July 28, 2005

Home>News>

Celgene’s Q2 Profit Surges on Drug Sales

Celgene’s Q2 Profit Surges on Drug Sales

Jessica Perry//July 28, 2005

Summit drugmaker Celgene (Nasdaq: CELG) has reported a more than fourfold increase in its secSummit drugmaker Celgene (Nasdaq: CELG) has reported a more than fourfold increase in its sec

<

NJBIZ Conversations

Dr. Tara Chalakani, the CEO of Preferred Behavioral Health Group, speaks with NJBIZ Editor Jeff Kanige on March 7, 2023.

NJBIZ Conversations: Tara Chalakani

Dr. Tara Chalankani, the CEO of Preferred Behavioral Health Group, talks about the problems she and her s[...]

Latest Headlines

Havemeyer Arch, Ramapo College of New Jersey

Senate holds first FY2024 NJ budget hearing in Mahwah

22/3/2023
The Vitamin Shoppe has opened a new franchise location in Valparaiso, Ind.

Vitamin Shoppe parent gets unsolicited buyout offer

22/3/2023
On March 21, Choose New Jersey announced the official opening of its new office in Tel Aviv, Israel.

Choose New Jersey opens Israel office

22/3/2023
U.S. Rep Bonnie Watson Coleman is flanked by local elected officials and BeiGene employees during a beam signing ceremony on March 21, 2023, at the Princeton West Innovation Campus in Hopewell, where the company is building a new facility that will provide state-of-the-art commercial-state U.S. biologic pharmaceutical manufacturing, late-state research and clinical development capabilities.

BeiGene reaches milestone at $700M Hopewell facility

22/3/2023
Phase 1 upgrades at Cambridge Rehabilitation & Healthcare Center in Moorestown included a 4,000-square-foot therapy gym.

Cambridge Rehabilitation completes Phase 1 upgrades

21/3/2023